Fosfomycin Tromethamine
3 NDCs across 3 manufacturers|3 Generic,0 Brand
Fosfomycin Tromethamine is used to treat escherichia coli infections, gram-positive bacterial infections, klebsiella infections, proteus infections, pyelonephritis and serratia infections, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Dec 19, 1996, and the first generic was approved Oct 6, 2020. In 2024, Medicare Part D spent $20 million on Fosfomycin Tromethamine across 129,000 claims for 71,000 beneficiaries.
Fosfomycin Tromethamine is available as 3 NDCs from 3 manufacturers (3 generic, 0 brand), with NADAC prices from $26.22 to $26.22 per EA. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
3
3G / 0B
Manufacturers
3
competing in market
Price Spread
$26.22 – $26.22
per EA
7d Activity
avg -2.0% WoW · of 3 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Amneal Pharmaceuticals NY LLC manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
3 manufacturers producing FOSFOMYCIN TROMETHAMINE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
FOSFOMYCIN 3 GM SACHET | $26.2204 per EA | -2.00% |
FOSFOMYCIN 3 GM SACHET | $26.2204 per EA | -2.00% |
FOSFOMYCIN 3 GM SACHET | $26.2204 per EA | -2.00% |
Frequently Asked Questions
What is Fosfomycin Tromethamine used to treat?
Fosfomycin Tromethamine is used to treat escherichia coli infections, gram-positive bacterial infections, klebsiella infections, proteus infections, pyelonephritis and serratia infections, per the National Library of Medicine's MED-RT classification.
When did Fosfomycin Tromethamine become available as a generic?
FDA approved the first generic Fosfomycin Tromethamine (ANDA) on Oct 6, 2020.
How much does Medicare spend on Fosfomycin Tromethamine?
In 2024, Medicare Part D spent $20 million on Fosfomycin Tromethamine across 129,000 claims for 71,000 beneficiaries.
How many Fosfomycin Tromethamine products are on the market?
The Fosfomycin Tromethamine drug market contains 3 NDCs from 3 manufacturers — 3 generic and 0 brand products.
What is the price range for Fosfomycin Tromethamine?
NADAC reference prices for Fosfomycin Tromethamine range from $26.2204 to $26.2204 per EA.
Which manufacturers make Fosfomycin Tromethamine?
3 manufacturers list Fosfomycin Tromethamine in NADAC. Ranked by number of NDCs, the largest are Amneal Pharmaceuticals NY LLC (1), Ascend Laboratories, LLC (1), Cipla USA Inc. (1).
How has the price of Fosfomycin Tromethamine changed recently?
Over the past 7 days, 0 Fosfomycin Tromethamine NDCs rose and 3 fell, with a market-wide average change of -2.0%.